UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-Q


(Mark One)

[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2007 or

 

[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to ___________________

Commission File Number 0-22529

inTEST Corporation
(Exact Name of Registrant as Specified in its Charter)

Delaware
(State or other jurisdiction of incorporation or organization)

22-2370659
(I.R.S. Employer Identification Number)

 

7 Esterbrook Lane
Cherry Hill, New Jersey 08003
(Address of principal executive offices, including zip code)

(856) 424-6886
(Registrant's Telephone Number, including Area Code)


Indicate by check X whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES   X       NO ___

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check One):
Large accelerated filer  ___                     Accelerated filer  ___                    Non-accelerated filer    X  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ___    NO   X    

Number of shares of Common Stock, $.01 par value, outstanding as of October 31, 2007:

9,527,206


 

inTEST CORPORATION

INDEX

 

 

PART I.

FINANCIAL INFORMATION

 

 

Page

Item 1.

Financial Statements (Unaudited)

 

 

 

 

 

Consolidated Balance Sheets as of September 30, 2007 and December 31, 2006

1

 

Consolidated Statements of Operations for the three months and nine months ended September 30,
   2007 and 2006


2

 

Consolidated Statements of Comprehensive Earnings (Loss) for the three months and nine
   months ended September 30, 2007 and 2006


3

 

Consolidated Statement of Stockholders' Equity for the nine months ended September 30, 2007

4

 

Consolidated Statements of Cash Flows for the nine months ended September 30, 2007 and 2006

5

 

Notes to Consolidated Financial Statements

6 - 14

 

 

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

15 - 23

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

23 - 24

 

 

 

Item 4.

Controls and Procedures

24

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

25

 

 

 

Item 1A.

Risk Factors

25

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

25

 

 

 

Item 3.

Defaults Upon Senior Securities

25

 

 

 

Item 4.

Submission of Matters to a Vote of Securities Holders

25

 

 

 

Item 5.

Other Information

25

 

 

 

Item 6.

Exhibits

25

 

 

Signatures

26

Index to Exhibits

26

 


 

 

inTEST CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)

 Sept. 30, Dec. 31,
 2007 2006
ASSETS: -------- --------
Current assets:
 Cash and cash equivalents $10,659 $13,174
 Trade accounts and notes receivable, net of allowance for
 doubtful accounts of $116 and $133, respectively 7,873 8,678
 Inventories 6,149 6,193
 Prepaid expenses and other current assets  1,257  758
 Total current assets  25,938  28,803

Property and equipment:
 Machinery and equipment 7,622 7,976
 Leasehold improvements  3,379  3,256
 11,001 11,232
 Less: accumulated depreciation  (8,156)  (7,904)
 Net property and equipment  2,845  3,328

Other assets 754 700
Goodwill 2,784 2,629
Intangible assets, net  281  299
 Total assets $32,602 $35,759
 ======= =======
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 Accounts payable $ 2,858 $ 3,145
 Accrued wages and benefits 1,822 1,894
 Accrued warranty 529 857
 Accrued sales commissions 449 418
 Other accrued expenses 953 1,000
 Domestic and foreign income taxes payable 166 971
 Capital lease obligations 7 7
 Deferred rent  118  118
 Total current liabilities  6,902  8,410
Capital lease obligations, net of current portion 10 16
Deferred rent, net of current portion  422  511
 Total liabilities  7,334  8,937

Commitments and contingencies

Stockholders' equity:
 Preferred stock, $0.01 par value; 5,000,000 shares authorized;
 no shares issued or outstanding - -
 Common stock, $0.01 par value; 20,000,000 shares authorized;
 9,666,505 and 9,510,755 shares issued, respectively 97 95
 Additional paid-in capital 24,719 24,515
 Retained earnings 355 2,914
 Accumulated other comprehensive income 1,109 609
 Treasury stock, at cost; 163,686 and 212,050 shares, respectively  (1,012)  (1,311)
 Total stockholders' equity  25,268  26,822
 Total liabilities and stockholders' equity $32,602 $35,759
 ======= =======

See accompanying Notes to Consolidated Financial Statements.

- 1 -

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)



 Three Months Ended Nine Months Ended
 Sept. 30, Sept. 30,
 ------------------ ------------------
 2007 2006 2007 2006
 -------- -------- -------- --------
Net revenues $13,114 $16,566 $37,294 $49,187
Cost of revenues 7,981 9,643 23,130 28,019
 ------- ------- ------- -------
 Gross margin 5,133 6,923 14,164 21,168
 ------- ------- ------- -------

Operating expenses:
 Selling expense 2,121 2,232 6,578 6,954
 Engineering and product development
 expense 1,364 1,775 4,162 4,500
 General and administrative expense 1,970 1,984 6,181 6,111
 ------- ------- ------- -------
 Total operating expenses 5,455 5,991 16,921 17,565
 ------- ------- ------- -------
Operating income (loss) (322) 932 (2,757) 3,603
 ------- ------- ------- -------
Other income (expense):
 Interest income 89 98 306 226
 Interest expense - (3) (1) (4)
 Other 59 (10) 90 7
 ------- ------- ------- -------
 Total other income 148 85 395 229
 ------- ------- ------- -------
Earnings (loss) before income taxes (174) 1,017 (2,362) 3,832
Income tax expense 78 509 197 1,042
 ------- ------- ------- -------
 Net earnings (loss) $ (252) $ 508 $(2,559) $ 2,790
 ======= ======= ======= =======

Net earnings (loss) per common
 share - basic $(0.03) $0.06 $(0.28) $0.31

Weighted average common shares
 outstanding-basic 9,216,443 9,053,603 9,196,557 9,020,173

Net earnings (loss) per common
 share - diluted $(0.03) $0.06 $(0.28) $0.31

Weighted average common and common
 share equivalents outstanding-diluted 9,216,443 9,264,809 9,196,557 9,152,747

 

See accompanying Notes to Consolidated Financial Statements.

- 2 -


 

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In thousands)
(Unaudited)

 Three Months Ended Nine Months Ended
 Sept. 30, Sept. 30,
 ------------------ -----------------
 2007 2006 2007 2006
 ------ ------ ------- ------

Net earnings (loss) $ (252) $ 508 $(2,559) $2,790

Foreign currency translation adjustments 487 (115) 500 322
 ------ ------ ------- ------

Comprehensive earnings (loss) $ 235 $ 393 $(2,059) $3,112
 ====== ====== ======= ======

See accompanying Notes to Consolidated Financial Statements.

- 3 -


inTEST CORPORATION
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
(In thousands, except share data)
(Unaudited)

 Accumulated
 Common Stock Addt'l Other Total
 ---------------- Paid-In Retained Comprehensive Treasury Stockholders'
 Shares Amount Capital Earnings Earnings/(Loss) Stock Equity
 --------- ------ -------- ----------- --------------- -------- -------------

Balance, December 31, 2006 9,510,755 $ 95 $24,515 $2,914 $ 609 $(1,311) $26,822

Net loss - - - (2,559) - - (2,559)

Other comprehensive income - - - - 500 - 500

Issuance of non-vested
 shares of restricted stock 162,000 2 (2) - - - -

Amortization of deferred
 compensation related to
 restricted stock - - 271 - - - 271

Options exercised 5,000 - 17 - - - 17

Forfeiture of non-vested
 shares of restricted
 stock (11,250) - - - - - -

Issuance of 48,364 shares of
 treasury stock to satisfy
 profit sharing liability - - (82) - - 299 217
 --------- ----- ------- ------ ------ ------- -------

Balance, September 30, 2007 9,666,505 $ 97 $24,719 $ 355 $1,109 $(1,012) $25,268
 ========= ===== ======= ====== ====== ======= =======

See accompanying Notes to Consolidated Financial Statements.

- 4 -



inTEST CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)
(Unaudited) 

 Nine Months Ended
 Sept. 30,
 ------------------
 2007 2006
 ------- -------
CASH FLOWS FROM OPERATING ACTIVITIES
 Net earnings (loss) $(2,559) $ 2,790
 Adjustments to reconcile net earnings (loss) to net cash
 provided by (used in) operating activities:
 Depreciation and amortization 1,017 1,128
 Foreign exchange loss 7 88
 Amortization of deferred compensation related to restricted stock 271 243
 Profit sharing expense funded through the issuance of treasury stock 217 225
 Gain on sale of fixed assets (36) (11)
 Proceeds from sale of demonstration equipment, net of gain 24 2
 Changes in assets and liabilities:
 Trade accounts and notes receivable 897 (1,182)
 Inventories 133 (516)
 Prepaid expenses and other current assets (468) (361)
 Other assets (33) (51)
 Accounts payable (319) 1,738
 Accrued wages and benefits (101) 535
 Accrued warranty (332) 5
 Accrued sales commissions 27 57
 Accrued restructuring and other charges - (79)
 Other accrued expenses (54) 3
 Domestic and foreign income taxes payable (817) 576
 Deferred rent (88) (88)
 ------- -------
Net cash provided by (used in) operating activities (2,214) 5,102
 ------- -------

CASH FLOWS FROM INVESTING ACTIVITIES
 Purchase of property and equipment (521) (551)
 Proceeds from sale of property and equipment 66 38
 ------- -------
Net cash used in investing activities (455) (513)
 ------- -------

CASH FLOWS FROM FINANCING ACTIVITIES
 Repayment of capital lease obligations (6) (22)
 Proceeds from stock options exercised 17 98
 ------- -------
Net cash provided by financing activities 11 76
 ------- -------
Effects of exchange rates on cash 143 100
 ------- -------
Net cash provided by (used in) all activities (2,515) 4,765
Cash and cash equivalents at beginning of period 13,174 7,295
 ------- -------

Cash and cash equivalents at end of period $10,659 $12,060
 ======= =======

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Restricted stock awards granted $ 675 $ -
 ======= =======
Unvested restricted stock awards forfeited $ 42 $ -
 ======= =======
Cash payments for:
 Domestic and foreign income taxes $ 825 $ 451
 Interest 1 4

See accompanying Notes to Consolidated Financial Statements.

- 5 -